Anaplastic thyroid cancer-derived cells are sensitive to TRAIL-induced apoptosis, indicating that TRAIL is a promising therapeutic agent [9]. Here, TNFSF10 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.